Comparing Nintedanib vs Ofev
| Nintedanib | Ofev (nintedanib) |
|
|---|
| Nintedanib | Ofev (nintedanib) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis, Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease. Nintedanib may also be... View more |
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis, Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease. Ofev may also be used... View more |
Related suggestions Idiopathic Pulmonary Fibrosis
Systemic Sclerosis-Associated Interstitial Lung Disease
|
|||||||
| More about Nintedanib | More about Ofev (nintedanib) | ||||||||
| Ratings & Reviews | |||||||||
|
Nintedanib has an average rating of 7.7 out of 10 from a total of 36 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 6% reported a negative effect. |
Ofev has an average rating of 7.6 out of 10 from a total of 27 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Nintedanib side effects |
View all Ofev side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ofev prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Ofev |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
9.5 hours |
9.5 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 252 drugs are known to interact with Nintedanib:
|
A total of 252 drugs are known to interact with Ofev:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
October 15, 2014 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Ofev
Ofev (nintedanib) is used to treat a lung disease called idiopathic pulmonary fibrosis, and ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Esbriet
Esbriet ((pirfenidone) may be used to treat adults with idiopathic pulmonary fibrosis (IPF), a lung ...
Tofidence
Tofidence (tocilizumab-bavi) is administered as an intravenous infusion by a healthcare provider ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.